LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)

businesswire

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) – NEWSnet – News… as it used to be

More Press Releases

May 26, 2026

MEXC Lists Solstice Finance (SLX) with 200,000 SLX and 40,000 USDT Airdrop+ Rewards

May 26, 2026

Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress

May 26, 2026

Tycho.AI Validates Halley VTOL UAS with Successful C-UAS and One-Way Attack Demonstrations at T-REX 26-2

May 26, 2026

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)

MEXC Lists Solstice Finance (SLX) with 200,000 SLX and 40,000 USDT Airdrop+ Rewards

Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress

Tycho.AI Validates Halley VTOL UAS with Successful C-UAS and One-Way Attack Demonstrations at T-REX 26-2

Cavalier Cleaners Explains How to Prepare for Your First Alterations Appointment